SCHEMBL6490888

SCHEMBL6490888

CC(C)(C)[CH][C@@H](COc1ccccc1)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 4/20 0.43
LMNA P02545 2/20 0.41
MAOA P21397 1/20 0.38
PTGS1 P23219 1/20 0.38
MTNR1A P48039 3/20 0.38
MTNR1B P49286 3/20 0.38
SCN4A P35499 2/20 0.37
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP3A4 P08684 2/20 0.34
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
TSHR P16473 2/20 0.34
NPC1 O15118 1/20 0.34
MTOR P42345 1/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8429746 0.85 CYP2D6 (0.43) CYP2D6LMNAMAOAPTGS1MTNR1A
SCHEMBL714416 0.85 CYP2D6 (0.43) CYP2D6LMNAMAOAPTGS1MTNR1A
SCHEMBL817869 0.85 CYP2D6 (0.43) CYP2D6LMNAMAOAPTGS1MTNR1A
SCHEMBL19548837 0.84 MAOB (0.39) LMNAALDH1A1HSD17B10KDM4EKMT2A
SCHEMBL16059015 0.84 MAOB (0.39) LMNAALDH1A1HSD17B10KDM4EKMT2A
SCHEMBL17499062 0.84 MAOB (0.39) LMNAALDH1A1HSD17B10KDM4EKMT2A
SCHEMBL6507499 0.83 LMNA (0.49) CYP2D6LMNAMAOAPTGS1MTNR1A
SCHEMBL6137275 0.78 CYP2D6 (0.42) CYP2D6LMNAMAOAPTGS1MTNR1A
SCHEMBL6137281 0.78 CYP2D6 (0.42) CYP2D6LMNAMAOAPTGS1MTNR1A
SCHEMBL9794052 0.78 CYP2D6 (0.42) CYP2D6LMNAMAOAPTGS1MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222247-A1 Chroman derivatives BAYER HEALTHCARE AG (DE) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222247-A1 Chroman derivatives CHRM3, CHRNB3, ADRB3 CYP2D6 2316/4885LMNA 1138/4885MAOA 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.